Loading...
•
Dec 31, 2020
Globus Medical Q4 2020 Earnings Report
Globus Medical's Q4 2020 results were announced, featuring a 10.3% increase in worldwide net sales and GAAP net income reaching $53.0 million.
Key Takeaways
Globus Medical reported a strong fourth quarter in 2020, with worldwide net sales increasing by 10.3% compared to the same period in 2019. The growth was driven by Enabling Technologies and US Spine. The company's GAAP net income for the quarter was $53.0 million, and non-GAAP diluted EPS was $0.58.
Worldwide net sales increased by 10.3% compared to Q4 2019, reaching $233.4 million.
GAAP net income for the quarter was $53.0 million, representing 22.7% of net sales.
GAAP diluted EPS was $0.52, while non-GAAP diluted EPS was $0.58.
Enabling Technologies led growth, up 30% in the quarter, with US Spine growing by 12%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company announced full year 2021 guidance with expected net sales of $880 million and non-GAAP diluted earnings per share of $1.83.
Positive Outlook
- Expected net sales of $880 million for full year 2021.
- Non-GAAP diluted earnings per share of $1.83 for full year 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...